Cargando…
Non-small-cell lung cancer resectability: diagnostic value of PET/MR
PURPOSE: To assess the diagnostic performance of PET/MR in patients with non-small-cell lung cancer. METHODS: Fifty consecutive consenting patients who underwent routine (18)F-FDG PET/CT for potentially radically treatable lung cancer following a staging CT scan were recruited for PET/MR imaging on...
Autores principales: | Fraioli, Francesco, Screaton, Nicholas J., Janes, Samuel M., Win, Thida, Menezes, Leon, Kayani, Irfan, Syed, Rizwan, Zaccagna, Fulvio, O’Meara, Celia, Barnes, Anna, Bomanji, Jamshed B., Punwani, Shonit, Groves, Ashley M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244545/ https://www.ncbi.nlm.nih.gov/pubmed/25120040 http://dx.doi.org/10.1007/s00259-014-2873-9 |
Ejemplares similares
-
Synergistic application of pulmonary (18)F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF)
por: Fraioli, Francesco, et al.
Publicado: (2019) -
Evolution of (18)F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation
por: Thornton, Andrew, et al.
Publicado: (2022) -
Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling
por: Boscolo Galazzo, Ilaria, et al.
Publicado: (2016) -
Inital experience of imaging cardiac sarcoidosis using hybrid PET-MR - a technologist's case study
por: O'Meara, Celia, et al.
Publicado: (2013) -
Hybrid PET/MR metabolic imaging of the reperfused infarct - new biology, future directions
por: White, Steven K, et al.
Publicado: (2015)